If this becomes a medical reality, diabetes patients with transplanted insulin-producing donor cells in their abdominal cavity do not have to take immunosuppressants for the rest of their life – medication which involves a high risk of infections and cancer.
Researchers also envision using the innovation in the treatment of certain types of cancer.
The Trondheim Capsule
The new capsule, called TAM (the Trondheim Alginate Microcapsule), is designed with a view to camouflage the insulin-producing cells to the body’s immune system.
”If the capsule is to function well, it needs to be suitably porous so that it allows nutrients to enter the insulin cells while insulin is transported out. It must be suitably small, and it must be stabile so it doesn’t swell and gradually break. We seem to be in the process of solving all these challenges," says Research Fellow Yrr Mørch from the Capsule Group at NTNU.
Her research environment, headed by Professor Gudmund Skjåk-Bræk, participates in an international cooperation called «The Chicago Project». The aim is to find a functional cure for diabetes type 1.
A solution around the corner
Alginate capsules with insulin cells are currently not used in the treatment of diabetes patients, even though the idea is far from new. As early as in the 1990s, an American had an alginate capsule with insulin cells produced in Trondheim implanted.
It appeared to be a success, but how well the old capsule actually functioned remained unanswered as the American had also had a kidney transplant and already took immunosuppressants.
Animal experiments later revealed that the capsule did not function satisfactorily. The main reason being polylysine, a substance used on the capsule’s outside to improve stability and make it less porous. This substance is toxic and triggers the immune system, which results in immune cells attaching to the capsule surface and hampering the diffusion of substances in and out of the capsule. The result is cell death.
Thorough basic research and several doctoral degrees later, the solution to the immune problem related to the transplant of capsules with insulin producing cells appears to be close. However, many years are likely to pass before the method can be used in patients. Stay updated on the development at: www.ntnu.no/forskning/alginatkapsler
Alginate is a long sugar molecule that stiffens kelp in the same way as cellulose makes the trees stand upright. Kelp has been researched at NTNU/former NTH for 50 years. Several of the alginate’s secrets are therefore revealed, including its structure.
Researchers have managed to isolate, clone and produce in large scale an enzyme involved in the construction of the alginate in different ways. That means that the researchers themselves can build the nanostructure of alginate so the molecule gets the desired properties.
Researchers envision tailoring different alginate capsules for individual use in the near future.
By Nina Tveter/Gemini
Yrr Mørch | alfa
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences